Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,192 | -42,759 | -34,443 | -22,641 | -10,340 |
| Depreciation Amortization | 34 | 144 | 113 | 75 | 37 |
| Accounts payable and accrued liabilities | -1,483 | -598 | -721 | -439 | -1,993 |
| Other Working Capital | -5,396 | -3,491 | -3,217 | -3,048 | -4,099 |
| Other Operating Activity | 3,348 | 4,615 | 3,810 | 2,475 | 2,918 |
| Operating Cash Flow | $-16,689 | $-42,089 | $-34,458 | $-23,578 | $-13,477 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -102 | -12 | -12 | N/A | N/A |
| Purchase Of Investment | -8,485 | -170,662 | -116,266 | -44,656 | -27,546 |
| Sale Of Investment | 25,552 | 76,567 | 52,779 | 32,095 | 17,595 |
| Investing Cash Flow | $16,965 | $-94,107 | $-63,499 | $-12,561 | $-9,951 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -11 | -11 | -11 | -11 |
| Common Stock Issued | 222 | 121,108 | 120,824 | 119,701 | 8,938 |
| Other Financing Activity | 0 | -84 | -84 | -590 | -222 |
| Financing Cash Flow | $222 | $121,013 | $120,729 | $119,100 | $8,705 |
| Beginning Cash Position | 18,914 | 34,097 | 34,097 | 34,097 | 34,097 |
| End Cash Position | 19,412 | 18,914 | 56,869 | 117,058 | 19,374 |
| Net Cash Flow | $498 | $-15,183 | $22,772 | $82,961 | $-14,723 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,689 | -42,089 | -34,458 | -23,578 | -13,477 |
| Capital Expenditure | -102 | -12 | -12 | N/A | N/A |
| Free Cash Flow | -16,791 | -42,101 | -34,470 | -23,578 | -13,477 |